MAPK1 and esophageal squamous cell carcinoma: Our study revealed that GK‐IT1 competed with DUSP6 to attenuate the interaction between DUSP6 and MAPK1, leading to activation of the ERK/MAPK pathway, thereby promoting progression of ESCC.